Portal de Periódicos da CAPES

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

2023; Massachusetts Medical Society; Volume: 388; Issue: 21 Linguagem: Inglês

10.1056/nejmoa2214924

1533-4406

Fadima Cheick Haidara, Ama Umesi, Samba O. Sow, Magnus Ochoge, Fatoumata Diallo, Abdulazeez Imam, Youssouf Traoré, Lucy Affleck, Moussa Doumbia, Bubacarr Daffeh, Mamoudou Kodio, Oghenebrume Wariri, Awa Traoré, Edrissa Jallow, Beate Kampmann, Dhananjay Kapse, Prasad S. Kulkarni, Asha D. Mallya, Sunil Goel, Pankaj Sharma, Annamraju D. Sarma, Nikhil Avalaskar, F. Marc LaForce, Mark R. Alderson, Abdi Naficy, Steve Lamola, Yuxiao Tang, Lionel Martellet, Nancy Hosken, Evangelos Simeonidis, Jo Anne Welsch, Milagritos D. Tapia, Ed Clarke,

Respiratory viral infections research

An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a pentavalent vaccine targeting the A, C, W, Y, and X serogroups, have been limited.